Burden of non-communicable disease studies in Europe: a systematic review of data sources and methodological choices.
Journal
European journal of public health
ISSN: 1464-360X
Titre abrégé: Eur J Public Health
Pays: England
ID NLM: 9204966
Informations de publication
Date de publication:
01 04 2022
01 04 2022
Historique:
pubmed:
12
1
2022
medline:
6
4
2022
entrez:
11
1
2022
Statut:
ppublish
Résumé
Assessment of disability-adjusted life years (DALYs) resulting from non-communicable diseases (NCDs) requires specific calculation methods and input data. The aims of this study were to (i) identify existing NCD burden of disease (BoD) activities in Europe; (ii) collate information on data sources for mortality and morbidity; and (iii) provide an overview of NCD-specific methods for calculating NCD DALYs. NCD BoD studies were systematically searched in international electronic literature databases and in grey literature. We included all BoD studies that used the DALY metric to quantify the health impact of one or more NCDs in countries belonging to the European Region. A total of 163 BoD studies were retained: 96 (59%) were single-country or sub-national studies and 67 (41%) considered more than one country. Of the single-country studies, 29 (30%) consisted of secondary analyses using existing Global Burden of Disease (GBD) results. Mortality data were mainly derived (49%) from vital statistics. Morbidity data were frequently (40%) drawn from routine administrative and survey datasets, including disease registries and hospital discharge databases. The majority (60%) of national BoD studies reported mortality corrections. Multimorbidity adjustments were performed in 18% of national BoD studies. The number of national NCD BoD assessments across Europe increased over time, driven by an increase in BoD studies that consisted of secondary data analysis of GBD study findings. Ambiguity in reporting the use of NCD-specific BoD methods underlines the need for reporting guidelines of BoD studies to enhance the transparency of NCD BoD estimates across Europe.
Sections du résumé
BACKGROUND
Assessment of disability-adjusted life years (DALYs) resulting from non-communicable diseases (NCDs) requires specific calculation methods and input data. The aims of this study were to (i) identify existing NCD burden of disease (BoD) activities in Europe; (ii) collate information on data sources for mortality and morbidity; and (iii) provide an overview of NCD-specific methods for calculating NCD DALYs.
METHODS
NCD BoD studies were systematically searched in international electronic literature databases and in grey literature. We included all BoD studies that used the DALY metric to quantify the health impact of one or more NCDs in countries belonging to the European Region.
RESULTS
A total of 163 BoD studies were retained: 96 (59%) were single-country or sub-national studies and 67 (41%) considered more than one country. Of the single-country studies, 29 (30%) consisted of secondary analyses using existing Global Burden of Disease (GBD) results. Mortality data were mainly derived (49%) from vital statistics. Morbidity data were frequently (40%) drawn from routine administrative and survey datasets, including disease registries and hospital discharge databases. The majority (60%) of national BoD studies reported mortality corrections. Multimorbidity adjustments were performed in 18% of national BoD studies.
CONCLUSION
The number of national NCD BoD assessments across Europe increased over time, driven by an increase in BoD studies that consisted of secondary data analysis of GBD study findings. Ambiguity in reporting the use of NCD-specific BoD methods underlines the need for reporting guidelines of BoD studies to enhance the transparency of NCD BoD estimates across Europe.
Identifiants
pubmed: 35015851
pii: 6500281
doi: 10.1093/eurpub/ckab218
pmc: PMC8975530
doi:
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
289-296Investigateurs
Balázs Ádám
(B)
Ala'a Alkerwi
(A)
Boris Bikbov
(B)
Anette Kocbach Bølling
(AK)
Susanne Breitner
(S)
Sarah Cuschieri
(S)
Christina C Dahm
(CC)
Terje Andreas Eikemo
(TA)
Florian Fischer
(F)
Alberto Freitas
(A)
Juan Manuel García-González
(JM)
Federica Gazzelloni
(F)
Mika Gissler
(M)
Brigita Hengl
(B)
Paul Hynds
(P)
Gaetano Isola
(G)
Lea S Jakobsen
(LS)
Zubair Kabir
(Z)
Ann Kristin Knudsen
(AK)
Naime Meriç Konar
(NM)
Carina Ladeira
(C)
Aaron Liew
(A)
Marjeta Majer
(M)
Enkeleint A Mechili
(EA)
Vildan Mevsim
(V)
Milena Santric Milicevic
(MS)
Louise Mitchell
(L)
Lorenzo Monasta
(L)
Stefania Mondello
(S)
Evangelia Nena
(E)
Edmond S W Ng
(ESW)
Vikram Niranjan
(V)
Rónán O'Caoimh
(R)
Mark Ryan O'Donovan
(MR)
Alberto Ortiz
(A)
Elena Pallari
(E)
Panagiotis Petrou
(P)
Miguel Reina Ortiz
(MR)
Silvia Riva
(S)
Hanène Samouda
(H)
João V Santos
(JV)
Cornelia Melinda Adi Santoso
(CM)
Tugce Schmitt
(T)
Dimitrios Skempes
(D)
Ana Catarina Sousa
(AC)
Aleksandar Stevanovic
(A)
Gerhard Sulo Natasa Terzic
(GSN)
Zorica Terzic-Supic
(Z)
Jovana Todorovic
(J)
Fimka Tozija
(F)
Brigid Unim
(B)
Lisa Van Wilder
(L)
Orsolya Varga
(O)
Francesco S Violante
(FS)
Grant M A Wyper
(GMA)
Informations de copyright
© The Author(s) 2022. Published by Oxford University Press on behalf of the European Public Health Association.
Références
Arch Public Health. 2020 Dec 31;78(1):137
pubmed: 33384020
Arch Public Health. 2016 Aug 22;74:37
pubmed: 27551405
Lancet Oncol. 2019 Nov;20(11):1493-1505
pubmed: 31521509
Popul Health Metr. 2012 Sep 12;10(1):19
pubmed: 22967055
PLoS One. 2018 May 30;13(5):e0197047
pubmed: 29847573
Eur J Public Health. 2020 Feb 1;30(1):2-3
pubmed: 31978226
Eur J Cancer. 2008 Jul;44(10):1345-89
pubmed: 18280139
Open Med. 2009;3(3):e123-30
pubmed: 21603045
Eur J Public Health. 2018 Aug 1;28(4):773-778
pubmed: 29697771
Bull World Health Organ. 1994;72(3):429-45
pubmed: 8062401
J Health Econ. 1997 Dec;16(6):703-30
pubmed: 10176780
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326
Ecancermedicalscience. 2016 May 12;10:641
pubmed: 27350787